These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 38954021)

  • 1. The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma.
    Xie Q; Zeng Y; Zhang X; Yu F
    Cancer Immunol Immunother; 2024 Jul; 73(9):171. PubMed ID: 38954021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 Oct; 81(4):690-703. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming.
    Liu S; Zhang S; Dong H; Jin X; Sun J; Zhou H; Jin Y; Li Y; Wu G
    BMC Cancer; 2024 Jun; 24(1):698. PubMed ID: 38849760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages as Targets in Hepatocellular Carcinoma Therapy.
    Liu YT; Mao ZW; Ding Y; Wang WL
    Mol Cancer Ther; 2024 Jun; 23(6):780-790. PubMed ID: 38310642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy.
    Zhang Y; Han G; Gu J; Chen Z; Wu J
    Front Immunol; 2024; 15():1429812. PubMed ID: 39170620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma.
    Li D; Zhang T; Guo Y; Bi C; Liu M; Wang G
    Cell Death Dis; 2024 Jul; 15(7):498. PubMed ID: 38997297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma.
    Hu N; Li H; Tao C; Xiao T; Rong W
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma.
    Xia Y; Brown ZJ; Huang H; Tsung A
    Cancer Med; 2021 Sep; 10(18):6374-6383. PubMed ID: 34390203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.
    Chen J; Feng W; Sun M; Huang W; Wang G; Chen X; Yin Y; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Gastroenterology; 2024 Jul; 167(2):264-280. PubMed ID: 38417530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
    Hu B; Lin JZ; Yang XB; Sang XT
    Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review).
    Yu M; Yu H; Wang H; Xu X; Sun Z; Chen W; Yu M; Liu C; Jiang M; Zhang X
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy.
    Helal IM; Kamal MA; Abd El-Aziz MK; El Tayebi HM
    Expert Rev Mol Med; 2024 Sep; 26():e18. PubMed ID: 39320855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor associated macrophages in hepatocellular carcinoma.
    Xu W; Cheng Y; Guo Y; Yao W; Qian H
    Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review.
    Zhang X; Yu C; Zhao S; Wang M; Shang L; Zhou J; Ma Y
    Cancer Med; 2023 Dec; 12(24):22109-22129. PubMed ID: 38098217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
    Li L; Ma SR; Yu ZL
    Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis.
    Wu L; Zhang X; Zheng L; Zhao H; Yan G; Zhang Q; Zhou Y; Lei J; Zhang J; Wang J; Xin R; Jiang L; Peng J; Chen Q; Lam SM; Shui G; Miao H; Li Y
    Cancer Immunol Res; 2020 May; 8(5):710-721. PubMed ID: 32122992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
    González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
    Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pumilio RNA binding family member 1 deficiency activates anti-tumor immunity in hepatocellular carcinoma via restraining M2 macrophage polarization.
    Yu Y; Nie G; Ren YW; Ouyang L; Ni CM
    Cell Cycle; 2024 Mar; 23(6):682-692. PubMed ID: 38794797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
    Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y; Dong H; Liu X; He F; Zhang X
    BMC Cancer; 2021 Jan; 21(1):31. PubMed ID: 33413205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.